Epigenetic targeting may provide new insight to personalized cancer treatment
A recent study led by researchers at the University of California, Merced (Merced, CA, USA) identified a gene and hormone combination that triggers prostate cancer, providing potential epigenetic drug targets for personalized medicine.
Please sign in or register for FREE
Sign in to EpigenomicsNet
Register to EpigenomicsNet – the epigenetics and epigenomics network
EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.